Sign Up For News And Updates

First Name:
Last Name:
E-mail Address:
Sign up for the following:





Address:
City:
State:
ZIP:
Mobile Phone:
Pfizer and Moderna 1st, 2nd and Boost Dose COVID 19 Vaccine available on walk in basis between 9AM - 11AM and 1PM - 3PM, including aged 5 - 11 vaccines

Plague

What is plague?

Plague is an infectious disease of animals and humans caused by the bacteria Yersinia pestis. Widespread epidemics of plague have had an enormous impact on human history: the first recorded plague epidemic began in Egypt in 541 AD and spread throughout Africa, Europe, and Asia killing approximately 50% of the population; the “Black Death” or “Great Pestilence” that began in 1346 was responsible for approximately 50 million deaths in Africa, Asia, and Europe; and the 1855 epidemic that began in China ultimately killed over 12 million people in India & China. Y. pestis is found naturally in rodents (rats, ground squirrels, prairie dogs, and other rodents on every continent except Australia) and their fleas. Plague may be transmitted to humans through the bite of an infected flea. Use of plague as a biological weapon would most likely be as an aerosol of the bacteria, entering the body through the lungs, resulting in what is known as pneumonic plague.

What are the symptoms of pneumonic plague?

  • Initial symptoms are fever, shortness of breath, and sometimes bloody or watery sputum.
  • Nausea, vomiting, abdominal pain, and diarrhea may also occur.
  • Pneumonia progresses to septic shock and death if not treated.
  • The time from inhalational exposure to death in humans before antibiotics were available for treatment was 2-6 days.

How soon after exposure would symptoms begin?

Symptoms appear in approximately 2-4 days following inhalation exposure to Y. pestis, but may appear from 1-6 days following exposure.

Can pneumonic plague be spread person to person?

  • Person to person transmission occurs only in face-to-face contact with ill persons.
  • Wearing a simple facial mask by the infected person and all close contacts significantly decreases the likelihood of pneumonic plague spreading.
  • Prophylactic antibiotic treatment is highly effective in preventing pneumonic plaque in those having face-to-face contact with infected persons.

Can plague be treated?

Early administration of certain antibiotics can be effective.

How likely is it that I will be exposed to plague?

Plague does not occur naturally in West Virginia. Historically, in the United States, the individual risk of disease from a bioterrorist attack has been very, very low.

What could be done in the event of an intentional release of plague?

Early recognition is key to managing cases of plague. Ill persons could be treated and appropriately isolated to prevent further spread. Public health officials, working rapidly, may be able to identify exposed persons and recommend preventive antibiotics for those at risk.


Plague Information for Public Health Officials

Bacteria

Unique Epidemiological Characteristics

  • No natural reservoir in West Virginia
  • A newly reported case should be urgently investigated considering:
    • travel to endemic area
    • importation of and exposure to an ill animal
    • BT
  • Incubation: 1-6 days by inhalation
  • Person-to-person transmission via droplets
  • Mortality: 100% without therapy – dire emergency
  • Environmental: bacteria is NOT long-lasting in the environment
  • Prophylaxis: effective with ciprofloxacin, doxycycline
  • Treatment: effective if begun early with streptomycin, gentamicin > cipro/doxy

Laboratory confirmation

  • Screening tests can be done by a hospital lab; confirmation by OLS

Employee health considerations

  • Exposed employees should be offered prophylaxis
  • Droplet precautions; employees who will have face-to-face contact with plague victims should be supplied with surgical masks

Lifesaving interventions – in order:

  • Recognition / reporting / case-finding (fever or cough in the setting of a known outbreak of plague) + early and appropriate therapy
  • Droplet isolation of cases
  • Contact tracing and prophylaxis
  • Collect and analyze risk information to identify source AND identify the exposed population to be offered prophylaxis and placed under surveillance.
  • Susceptibility testing; dissemination of susceptibility results

Training considerations

  • Physicians: recognition / treatment / reporting
  • ICPs: reporting, active surveillance procedures
  • Local health departments, regional epidemiologists: investigation
  • IDEP / DSDC / BPH: employee health / investigation / priorities for control

CDC–Plague Page